Results 171 to 180 of about 99,828 (263)

Expert Perspective: Hematologic Malignancies and Vasculitis

open access: yes
Arthritis &Rheumatology, Volume 77, Issue 10, Page 1305-1316, October 2025.
Michelle L. Robinette, Hetty E. Carraway
wiley   +1 more source

CLINICAL CONSIDERATIONS REGARDING VARIATIONS IN ORIGIN OF THE SUPERIOR THYROID ARTERY – A SYSTEMATIC REVIEW

open access: yesRomanian Journal of Oral Rehabilitation, 2018
Aim of the study: the superior thyroid artery (STA) is the main artery which vascularises the larynx and the thyroid gland. Being aware of the variations in origin of the STA can be useful during surgical procedures.
Victor Nimigean   +4 more
doaj  

A case report of variation in subclavian artery branches

open access: yes, 2007
The subclavian artery is a major branch of the Aorta. In the left, the subclavian artery arises from Aortic arch and in the right it arises from the Brachiocephalic trunk.
Mehrdad, J., Sadeghi, Y.
core  

Placental growth factor before 11 weeks for screening of preterm preeclampsia: The PreMoM study

open access: yesActa Obstetricia et Gynecologica Scandinavica, Volume 104, Issue 10, Page 1897-1906, October 2025.
In this multicenter study including 3448 women with singleton pregnancies in Spain, early placental growth factor (PlGF) measurement (<11 weeks) was compared with standard timing (11–13 weeks) for preterm preeclampsia screening. Early measurements showed no added benefit over models without PlGF.
Rocío López Mármol   +13 more
wiley   +1 more source

Cardiotoxicity in patients with acute myeloid leukaemia following anthracycline‐containing chemotherapy: A population‐based matched cohort study

open access: yesBritish Journal of Haematology, Volume 207, Issue 4, Page 1416-1424, October 2025.
Summary Anthracycline‐containing chemotherapy is associated with cardiovascular diseases (CVDs). While knowledge regarding the extent of cardiotoxicity in adult patients with acute myeloid leukaemia (AML) is sparse, anthracyclines remain a key component in the treatment.
Rikke Hedegaard Jensen   +10 more
wiley   +1 more source

Sclerosing diseases of the skin

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 23, Issue 10, Page 1282-1300, October 2025.
Summary Sclerosing skin diseases comprise a group of distinct dermatological conditions characterized by fibrotic changes that may severely impair patients’ quality of life. These conditions often present with cutaneous manifestations and, in some cases, may extend to extracutaneous tissues, potentially resulting in significant morbidity and mortality.
Yasamin Kalantari   +4 more
wiley   +1 more source

Tertiary Lymphoid Structures Across Organs: Context, Composition, and Clinical Levers

open access: yesImmunological Reviews, Volume 335, Issue 1, October 2025.
ABSTRACT Tertiary lymphoid structures (TLSs) arise in non‐lymphoid tissues in response to persistent antigen stimulation and chronic inflammation. Spanning organs from lung and liver to meninges, skin, and beyond, TLSs range from loose aggregates of immune cells to fully mature structures containing functional germinal centers (GC).
Stephane M. Guillaume   +3 more
wiley   +1 more source

Hypertension as an Adverse Event Potentially Impacting the Therapeutic Efficacy of Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma

open access: yesJournal of Gastroenterology and Hepatology, Volume 40, Issue 10, Page 2580-2590, October 2025.
ABSTRACT Background and Aim Atezolizumab plus bevacizumab is used as a first‐line treatment for unresectable hepatocellular carcinoma (uHCC). However, the relationship between its adverse events (AEs) and treatment efficacy remains unclear. In this study, we aimed to clarify this association.
Kazuki Maesaka   +29 more
wiley   +1 more source

Use of Superior Thyroid Artery as a Donor Vessel in Extracranial-Intracranial Revascularization Procedures: A Novel Technique [PDF]

open access: green, 2014
José Luis Cuevas   +5 more
openalex   +1 more source

Home - About - Disclaimer - Privacy